Discuss This Disease

4 free views remaining today

posterior polymorphous corneal dystrophy 2

ICD-10 Codes

Related ICD-10:

Description

Posterior Polymorphous Corneal Dystrophy-2 (PPCD2) is a rare and inherited condition that affects the cornea, specifically the endothelium.

Characteristics:

  • Formation of blister-like lesions within the corneal endothelium [3][9]
  • Regions of endothelial basement membrane thickening with associated corneal edema [3][9]
  • Abnormal cells in the endothelium that retain their ability to divide and extend onto the trabecular meshwork, potentially causing glaucoma in up to 40% of cases [4]

Genetic Link:

  • PPCD2 is caused by genetic mutations, specifically a missense mutation in the COL8A2 gene [8]
  • This gene encodes the alpha-2 chain of type VIII collagen, a short-chain collagen that is a component of endothelial basement membranes [8]

Clinical Presentation:

  • PPCD2 can present with various clinical features, including vesicular changes, endothelial band lesions, and irregular diffuse opacities of the posterior corneal stroma [12]
  • Corneal edema or elevated intraocular pressure may also be present in some cases [7][10]

Inheritance:

  • PPCD2 is inherited in an autosomal dominant manner, meaning that a single copy of the mutated gene is sufficient to cause the condition [5][6][11]

Additional Characteristics

  • Formation of blister-like lesions
  • Regions of endothelial basement membrane thickening with associated corneal edema
  • Abnormal cells in the endothelium
  • Genetic mutations specifically a missense mutation in the COL8A2 gene
  • Vesicular changes, endothelial band lesions, and irregular diffuse opacities of the posterior corneal stroma
  • Corneal edema or elevated intraocular pressure

Signs and Symptoms

Common Signs and Symptoms of Posterior Polymorphous Corneal Dystrophy 2 (PPCD2)

Posterior polymorphous corneal dystrophy 2 (PPCD2) is a rare eye disorder that can cause various signs and symptoms. While most cases are asymptomatic, some patients may experience the following:

  • Blurred vision: This is one of the most common ocular symptoms of PPCD2, which can be caused by the formation of blister-like lesions within the corneal endothelium [9].
  • Foreign body sensation: Some patients may feel like there's something in their eye, even when there's nothing physically present [1][9].
  • Eye pain: In some cases, PPCD2 can cause mild to moderate eye pain, which can be uncomfortable for the patient.
  • Photophobia: This is a sensitivity to light that can make it difficult for patients to tolerate bright lights or sunlight.
  • Lacrimation: Excessive tearing can also occur in some patients with PPCD2.

Other Possible Symptoms

In addition to these common signs and symptoms, PPCD2 may also be associated with other ocular abnormalities, such as:

  • Corneal edema: This is a condition where the cornea becomes swollen or inflamed.
  • Peripheral anterior synechiae: These are adhesions between the iris and the cornea that can cause vision problems.
  • Iris abnormalities: PPCD2 may also be associated with changes in the iris, such as corectopia (a displacement of the iris).
  • Decreased visual acuity: In some cases, PPCD2 can cause a decrease in visual sharpness or clarity.

It's essential to note that most patients with PPCD2 are asymptomatic and do not require treatment. However, if you're experiencing any of these symptoms, it's crucial to consult an eye care professional for proper evaluation and management.

References: [1] - [10] refer to the search results provided in the context block above.

Additional Symptoms

  • Eye pain
  • Lacrimation
  • Decreased visual acuity
  • Corneal edema
  • Foreign body sensation
  • Iris abnormalities
  • Peripheral anterior synechiae
  • photophobia
  • blurred vision

Diagnostic Tests

Based on the provided context, it appears that diagnostic tests for Posterior Polymorphous Corneal Dystrophy 2 (PPCD2) are not explicitly mentioned. However, I can provide some information on the general approach to diagnosing PPCD2.

  • Clinical diagnosis: PPCD2 can be diagnosed clinically, although early-onset disease may be difficult to distinguish from congenital hereditary endothelial dystrophy [1].
  • Genetic testing: Genetic testing can be undertaken to confirm the diagnosis of PPCD2 and facilitate genetic counseling [2]. This can provide accurate advice on prognosis and future family planning.
  • Imaging studies: In mild cases, further imaging studies may be required to confirm the diagnosis [5].

It's worth noting that PPCD2 is a rare condition, and diagnostic tests may not be widely available. A specialist referral may be necessary for an accurate diagnosis.

References:

[1] Context #2 [2] Context #2

Additional Diagnostic Tests

  • Genetic testing
  • Imaging studies
  • Clinical diagnosis

Treatment

Treatment Options for Posterior Polymorphous Corneal Dystrophy (PPCD)

Posterior polymorphous corneal dystrophy (PPCD) is a rare and complex eye condition that can be challenging to treat. While there are no specific medications that can cure PPCD, various treatments may help manage the symptoms and slow down disease progression.

  • Sodium chloride 5% drops and ointment: Mild cases of corneal edema associated with PPCD can be managed with sodium chloride 5% drops and ointment [1].
  • Hyperosmotic saline drops and ointments: In cases of corneal failure with corneal edema, hyperosmotic saline drops and ointments may be used [3].
  • Phototherapeutic keratectomy (PTK): PTK is a surgical procedure that uses a precisely tuned laser to remove areas of corneal tissue. This treatment can help improve vision by removing damaged or irregularly shaped corneal tissue [7].

It's essential to note that most patients with PPCD do not require therapy, and some may eventually need a penetrating keratoplasty (a surgical procedure where the diseased cornea is replaced with a healthy donor cornea) or other procedures for repairing the posterior surface of the eye [5]. Consultation with an eye care specialist is recommended to determine the best course of treatment.

References: [1] - Context result 4 [3] - Context result 3 [5] - Context result 5 [7] - Context result 7

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Posterior Polymorphous Corneal Dystrophy (PPCD)

Posterior polymorphous corneal dystrophy (PPCD) is a rare, hereditary condition that can be challenging to diagnose due to its variable clinical presentation. To accurately diagnose PPCD, it's essential to consider the differential diagnoses listed below:

  • Congenital endothelial dystrophy type 1 (CHED1): This condition shares certain morphological and clinical features with PPCD, making it a crucial differential diagnosis.
  • Iridocorneal endothelial syndrome (ICE): ICE is another rare condition that can present with similar symptoms to PPCD, including corneal edema and Descemet's membrane abnormalities.
  • Descemet's tears (Haab's striae): This condition involves tears in Descemet's membrane, which can be mistaken for PPCD due to its similar presentation.
  • Metabolic disorders: Certain metabolic conditions, such as mucopolysaccharidosis, can present with corneal opacities and abnormalities that may resemble PPCD.

Key Studies and Findings

Studies have highlighted the importance of differential diagnosis in PPCD. For instance:

  • A study by Cibis et al. (1982) [1] emphasized the need to differentiate between Descemet's tears and posterior polymorphous dystrophy bands.
  • Another study by Hirst et al. (1982) [2] discussed the clinical specular microscopy findings in PPCD, which can aid in differential diagnosis.

References

[1] Cibis GW, Tripathi RC. The differential diagnosis of Descemet's tears (Haab's striae) and posterior polymorpous dystrophy bands. A clinicopathologic study. Ophthalmology. 1982 Jun; 89 (6):614–620.

[2] Hirst LW, Waring GO., 3rd Clinical specular microscopy of posterior polymorphous endothelial dystrophy. Am J Ophthalmol.

Note: The references provided are based on the search results and may not be an exhaustive list of all relevant studies on this topic.

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0110856
core#notation
DOID:0110856
oboInOwl#hasDbXref
MIM:609140
IAO_0000115
A posterior polymorphous corneal dystrophy that has_material_basis_in heterozygous mutation in the COL8A2 gene on chromosome 1p34.3.
rdf-schema#label
posterior polymorphous corneal dystrophy 2
oboInOwl#hasExactSynonym
Ppcd2
rdf-schema#subClassOf
t370600
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
relatedICD
http://example.org/icd10/H18.50
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_5193
owl#annotatedSource
t370688

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.